ACCC sues Voltaren makers GlaxoSmithKline and Novartis for misleading consumers

SMH, 6 December 2017
Author: Esther Han
“Two pharma giants have been taken to the Federal Court for allegedly misleading osteoarthritis sufferers into paying 33 per cent more for a “more effective” product that offers “targeted relief”, when this was not the case.”
Find article here.